Havn Life Sciences Inc (HAVN.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
(Values in thousands)
| 04-2022 | 04-2021 | 04-2020 | |
| Sales | 276 | 0 | 0 |
| Cost of Goods | 187 | N/A | N/A |
| Gross Profit | 90 | N/A | N/A |
| Operating Expenses | 9,900 | 24,346 | 41 |
| Operating Income | -9,810 | -24,346 | -41 |
| Interest Expense | 64 | 17 | 0 |
| Other Income | -12,569 | -6,017 | 1 |
| Pre-tax Income | -22,444 | -30,381 | -41 |
| Net Income Continuous | -22,444 | -30,381 | -41 |
| Net Income | $-22,444 | $-30,381 | $-41 |
| EPS Basic Total Ops | -5.25 | -15.60 | -0.02 |
| EPS Basic Continuous Ops | -5.25 | -15.60 | N/A |
| EPS Diluted Total Ops | -5.25 | -15.60 | -0.02 |
| EPS Diluted Continuous Ops | -5.25 | -15.60 | N/A |
| EBITDA(a) | $-21,804 | $-25,759 | $-41 |